share_log

Vertex, Bluebird Both Get FDA Approval for Sickle Cell Gene Therapies

Vertex, Bluebird Both Get FDA Approval for Sickle Cell Gene Therapies

Vertex、Bluebird 都獲得了美國食品藥品管理局對鐮狀細胞基因療法的批准
道瓊斯 ·  2023/12/08 15:05

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論